Randomised trial of low-dose amiodarone in severe congestive heart failure

[1]  S. Yusuf,et al.  Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study. , 1992, Journal of the American College of Cardiology.

[2]  K. Nademanee.  The amiodarone odyssey. , 1992, Journal of the American College of Cardiology.

[3]  M. D. Freedman,et al.  Pharmacology and Pharmacokinetics of Amiodarone , 1991, Journal of clinical pharmacology.

[4]  Steven N. Singh,et al.  Ventricular Arrhythmias Associated with Congestive Heart Failure: The Role for Amiodarone , 1991, Journal of clinical pharmacology.

[5]  M. Rubenfire,et al.  Survival of Patients with Nonsustained Ventricular Tachycardia and Impaired Left Ventricular Function Treated with Low‐Dose Amiodarone , 1991, Journal of clinical pharmacology.

[6]  N. Kerin.  Crime, Misdemeanor, and Arrhythmia Decoding CAST , 1991, Journal of clinical pharmacology.

[7]  W. Mckenna,et al.  Prospective, double-blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy. , 1991, American heart journal.

[8]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[9]  S. Connolly,et al.  Post‐Myocardial Infarction Mortality in Patients With Ventricular Premature Depolarizations: Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Pilot Study , 1991, Circulation.

[10]  Side effects from amiodarone. , 1991, American heart journal.

[11]  M. Pfisterer,et al.  Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS) , 1990, Journal of the American College of Cardiology.

[12]  T. Therneau,et al.  Nonfatal myocardial infarction is, by itself, an inappropriate end point in clinical trials in cardiology. , 1990, Circulation.

[13]  J. Johns,et al.  Beneficial effects of low dose amiodarone in patients with congestive cardiac failure: a placebo-controlled trial. , 1989, Journal of the American College of Cardiology.

[14]  J. Podleśny,et al.  Determination of amiodarone and its metabolite desethylamiodarone in human plasma and serum. , 1989, Polish journal of pharmacology and pharmacy.

[15]  W. Rogers,et al.  Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. , 1989, The New England journal of medicine.

[16]  J. Mason.  Prediction of amiodarone-induced pulmonary toxicity. , 1989, The American journal of medicine.

[17]  W. Kübler,et al.  Long-term prognostic significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. , 1988, The American journal of cardiology.

[18]  Bigger Jt.  Why patients with congestive heart failure die: arrhythmias and sudden cardiac death. , 1987 .

[19]  J. Cleland,et al.  Clinical, haemodynamic, and antiarrhythmic effects of long term treatment with amiodarone of patients in heart failure. , 1987, British heart journal.

[20]  L. Mestroni,et al.  Ventricular arrhythmias in dilated cardiomyopathy: efficacy of amiodarone. , 1987, American heart journal.

[21]  M. Packer,et al.  Sudden unexpected death in patients with congestive heart failure: a second frontier. , 1985, Circulation.

[22]  M. Quiñones,et al.  Analysis of the spontaneous variability of ventricular arrhythmias: consecutive ambulatory electrocardiographic recordings of ventricular tachycardia. , 1985, The American journal of cardiology.

[23]  M. Gheorghiade,et al.  Ventricular arrhythmias in severe heart failure: incidence, significance, and effectiveness of antiarrhythmic therapy. , 1985, American heart journal.

[24]  L. Horowitz,et al.  Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity. , 1983, Journal of the American College of Cardiology.

[25]  L E Hinkle,et al.  Clinical Classification of Cardiac Deaths , 1982, Circulation.

[26]  E F Cook,et al.  Comparative Reproducibility and Validity of Systems for Assessing Cardiovascular Functional Class: Advantages of a New Specific Activity Scale , 1981, Circulation.

[27]  J. Kaski,et al.  Long‐term Management of Sustained, Recurrent, Symptomatic Ventricular Tachycardia with Amiodarone , 1981, Circulation.

[28]  M. Zelen.  A new design for randomized clinical trials. , 1979, The New England journal of medicine.

[29]  S. Pocock.  Group sequential methods in the design and analysis of clinical trials , 1977 .